Current Duke Appointments & Affiliations
Assistant Professor of Radiation Oncology
·
2024 - Present
Radiation Oncology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain Metastases.
Journal article Adv Radiat Oncol · November 2026 PURPOSE: Radionecrosis (RN) is a dose-limiting toxicity after stereotactic radiosurgery (SRS) for brain metastases and is hard to differentiate from treated tumor progression. The outcomes of patients with RN following SRS are poorly described, particularl ... Full text Link to item CiteEarly Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy.
Journal article Adv Radiat Oncol · October 2026 PURPOSE: To evaluate the local control (LC) outcomes and safety profile of stereotactic proton ablative radiation therapy (SPAR) for spine metastases in a highly selected patient population, with emphasis on reirradiation cases. METHODS AND MATERIALS: We r ... Full text Link to item CiteDesign and Implementation of Novel Internal Mini Fellowship Concentrations Within a Radiation Oncology Residency Program.
Journal article Int J Radiat Oncol Biol Phys · August 1, 2026 PURPOSE: Resident and faculty impressions of novel mini fellowship concentrations in multiple disease sites during radiation oncology training were assessed. METHODS AND MATERIALS: In 2022, mini fellowship concentrations in gynecologic brachytherapy, centr ... Full text Link to item CiteRecent Grants
Serum pro-N-cadherin as an early biomarker of radiation-induced heart disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030Phase 2 Randomized Clinical Trial Comparing the Safety and Efficacy of PULSAR-Integrated Radiotherapy + Pembrolizumab or Nivolumab Administered with or without STING-Agonist IMSA101 in Patients with Oligometastatic Non-Small Cell Lung Cancer and Rena
Clinical TrialPrincipal Investigator · Awarded by ImmuneSensor Therapeutics, Inc. · 2024 - 2024View All Grants
Education
Mayo Clinic, Alix School of Medicine ·
2016
M.D.